The data presented in Figures 1–3 demonstrate the ability of the PI3K/mTOR/Hsp90 inhibitors to modify the morphology of GBM cells and, most notably, to inhibit their migration, in a cell line-specific manner. Here, MTOR is linked to glioblastoma.